Primary and Metastatic Malignant Bone Lesions

Goldman's Cecil Medicine: Twenty Fourth Edition

Volumn 1, Issue , 2012, Pages 1325-1327

  Lerner, Adam ^a   Antman, Karen H ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84904378430     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-1604-7.00208-6     Document Type: Chapter

References (10)

1. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003, 348:694-701.
2. Meyers PA, Schwartz CL, Krailo MD, et al. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival-a report from the Children's Oncology Group. J Clin Oncol 2008, 26:633-638.
3. Balamuth NJ, Womer RB Ewing's sarcoma. Lancet Oncol 2010, 11:184-192. Opportunities for new treatment approaches in a sarcoma of children and adolescents, in which survival has improved from about 10% to about 75% with chemotherapy for localized tumors but patients with metastases still fare badly.
4. Geller DS, Gorlick R Osteosarcoma: a review of diagnosis, management, and treatment strategies. Clin Adv Hematol Oncol 2010, 8:705-718. Review including multiagent chemotherapy.
5. Jamil N, Howie S, Salter DM Therapeutic molecular targets in human chondrosarcoma. Int J Exp Pathol 2010, 91:387-393. Review.
6. O'Day K, Gorlick R Novel therapeutic agents for osteosarcoma. Expert Rev Anticancer Ther 2009, 9:511-523. New therapeutic approaches, including targeted agents, inhibitors of tumor microenvironment, and immunomodulatory agents.
7. Riedel RF, Larrier N, Dodd L, et al. The clinical management of chondrosarcoma. Curr Treat Options Oncol 2009, 10:94-106. This review highlights the need for a coordinated multidisciplinary approach to management of these patients.
8. Kansara M, Thomas D Molecular pathogenesis of osteosarcoma. DNA Cell Biol 2007, 26:1-18. Synoptic overview of molecular causes of osteosarcoma.
9. Maheshwari AV, Cheng EY Ewing sarcoma family of tumors. J Am Acad Orthop Surg 2010, 18:94-107. Review emphasizing marked improvements in survival for localized disease, but lesser improvements for metastatic or recurrent disease.
10. World Health Organization classification of tumors: tumors of soft tissue and bone 2002, IARC Press, Lyon, France.